Axa S.A. Aclaris Therapeutics, Inc. Transaction History

Axa S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$14.33 - $18.37 $260,806 - $334,334	-18,200 Closed	0 $0
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $237,874 - $331,604	18,200 New	18,200 $287,000
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $208,471 - $651,803	-263,888 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$2.13 - $7.06 $711,999 - $2.36 Million	-334,272 Reduced 55.88%	263,888 $578,000
Q1 2019 May 14, 2019	BUY	$5.63 - $7.84 $1.22 Million - $1.7 Million	216,212 Added 56.61%	598,160 $3.58 Million
Q2 2018 Aug 13, 2018	BUY	$16.46 - $20.33 $1.44 Million - $1.77 Million	87,250 Added 29.61%	381,948 $7.63 Million
Q1 2018 May 14, 2018	BUY	$17.08 - $25.64 $562,598 - $844,555	32,939 Added 12.58%	294,698 $5.16 Million
Q4 2017 Feb 13, 2018	BUY	$21.47 - $27.8 $5.62 Million - $7.28 Million	261,759	261,759 $6.46 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.